BDBM466116 US10793580, Example 216::[3-(1-ethyl-8-oxo- spiro[6,7-dihydro-4H- pyrazolo[3,4-c]azepine- 5,4'-tetrahydropyran]-3- yl)-2,2-dimethyl-propyl] 4- (4-acetylpiperazin-1- yl)sulfonylbenzoate

SMILES CCn1nc(CC(C)(C)COC(=O)c2ccc(cc2)S(=O)(=O)N2CCN(CC2)C(C)=O)c2CC3(CCOCC3)CNC(=O)c12

InChI Key InChIKey=HRNOVIQUHOLNRM-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 466116   

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM466116(US10793580, Example 216 | [3-(1-ethyl-8-oxo- spiro...)
Affinity DataIC50: <100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent